As of December 2024 Newron Pharmaceuticals has a market cap of €0.16 Billion. This makes Newron Pharmaceuticals the world's 8288th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.